Radiofrequency Ablation for BIII Thyroid Nodules
Radiofrequency Ablation for Indeterminate Bethesda III Thyroid Nodules
Columbia University
50 participants
Aug 1, 2020
OBSERVATIONAL
Conditions
Summary
The purpose of this observational chart review study is to evaluate the efficacy and safety of Radiofrequency Ablation (RFA) for treatment of indeterminate thyroid nodules before and after RFA procedure. This is a data collection study in which the investigators ask patients to give access to information generated before and after RFA treatment of their condition. The RFA procedure uses image guidance to place an electrode through the skin into the target area. In RFA, high-frequency electrical currents are passed through an electrode, creating a small region of heat to treat the lesion.
Eligibility
Inclusion Criteria1
- Indeterminate Bethesda III nodules that have been molecularly profiled benign with either Afirma Genomic Sequencing Classifier (GSC) or ThyroSeq v3 tests
Exclusion Criteria2
- cardiac arrthymias
- pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Ultrasound guided radiofrequency ablation (non-experimental)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05189808